JP Morgan lifts Clicks stake to 5.47% despite 34% share slide
What's the deal? JP Morgan Chase & Co. has raised its stake in South Africa's Clicks GroupDealroom has a profile for this one. Try Dealroom → to 5.47% from 5.07%, according to a regulatory filing dated July 30, 2026 — even as the retailer's shares have fallen 34% year-to-date.
By the numbers: The expanded holding is now worth about R2.75 billion (roughly $166 million), making JP Morgan the second-largest shareholder in Clicks, behind South Africa's Public Investment CorporationDealroom has a profile for this one. Try Dealroom →. Clicks shares dropped from R33.13 in January 2026 to R21.90.
What does Clicks do? The company runs 936 stores and 720 in-store pharmacies, making it one of the largest pharmacy-led retail chains in the region. It is led by chief executive officer Bertina Engelbrecht.
The financials: Despite the share decline, Clicks reported revenue of R26.74 billion in the first half of 2026, up 7.64% on the previous period. Profit rose 6.6% to R1.53 billion, and total assets climbed 11.1% to R23 billion.
Why now? The stock has faced sustained pressure through 2026, which the company attributes to consumer spending constraints and sector headwinds. JP Morgan's buying during that downturn suggests a bet on long-term value in a company with solid fundamentals.
The signal: The move points to continued global institutional interest in South Africa's healthcare retail sector, where Clicks remains a dominant player. It shows international capital is still drawn to resilient, consumer-driven emerging-market assets even amid volatility.
Read more: Shore Africa
